Back

Risk of stroke and transient ischemic attack after elective cardioversion of atrial fibrillation: A nationwide study in Finland

27 August 2022 (15:15 - 15:45)
Organised by:
Congress Presentation Part of: Stroke prevention by anticoagulation and appendage occlusion in atrial fibrillation Rhythm Control, Cardioversion ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Mrs Saga Itainen-Stromberg

Helsinki University Hospital, Helsinki (Finland)

4 More presentations in this session

Presentation thumbnail
Clinical risk prediction for left atrial appendage thrombus among patients with atrial fibrillation
Professor P. Kistler (Melbourne, AU)
Abstract Slides
Presentation thumbnail
Left atrial appendage occlusion versus standard of care in patients with atrial fibrillation and a prior thrombo-embolic event despite oral anticoagulant therapy: a propensity score matched comparison
Professor L. Boersma (Nieuwegein, NL)
Abstract Slides
Presentation thumbnail
Decreased device related thrombus and enhanced neo-endocardial tissue maturation with a new generation left atrial appendage closure (LAAC) device. An anticoagulation and antiplatelet free canin study
Professor W. Saliba (Cleveland, US)
Abstract Slides
Presentation thumbnail
Impact of ABC pathway adherence in high-risk patients with atrial fibrillation: an analysis from the ESC-EHRA EORP-AF long-term general registry
Doctor W. Ding (Liverpool, GB)
Abstract Slides

Access the full session

Session thumbnail
Stroke prevention by anticoagulation and appendage occlusion in atrial fibrillation

The Event

Event poster

ESC Congress 2022

27 August 2022 15:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources